New drug trial for Tough-to-Treat leukemia withdrawn before starting
NCT ID NCT06522373
Summary
This was a very early study designed to test the safety and side effects of an experimental drug called MT-0169 in patients with acute leukemia. It was intended for people whose cancer had come back, did not respond to standard treatments, or had small amounts of leftover disease after treatment. The study was withdrawn by the sponsor before any participants were enrolled.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for LEUKEMIA are added.
By submitting, you agree to our Terms of use
Conditions
Explore the condition pages connected to this study.